Regenevess Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$75K
- Investors
-
1
Regenevess General Information
Description
Developer of tissue-engineered vascular bypass grafts designed for improving surgical revascularization outcomes. The company integrates advanced biomaterials, scaffold engineering, and regenerative medicine techniques to create engineered vascular grafts with enhanced biocompatibility, structural integrity, and long-term patency, enabling healthcare providers and vascular surgeons to access safer, more durable, and more accessible alternatives to traditional grafting options for patients requiring vascular surgery.
Contact Information
Corporate Office
- Australia
Corporate Office
- Australia
Regenevess Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 07-Dec-2025 | $75K | Completed | Startup |
Regenevess Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Venture UWA | Accelerator/Incubator |
Regenevess FAQs
-
Where is Regenevess headquartered?
Regenevess is headquartered in Australia.
-
What industry is Regenevess in?
Regenevess’s primary industry is Therapeutic Devices.
-
Is Regenevess a private or public company?
Regenevess is a Private company.
-
What is Regenevess’s current revenue?
The current revenue for Regenevess is .
-
How much funding has Regenevess raised over time?
Regenevess has raised $75K.
-
Who are Regenevess’s investors?
Venture UWA has invested in Regenevess.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process